13th August,2014

Pharmacogenomics: New tool for Personalized

Medicine
Dr. Nayan Chaudhari

INTRODUCTION
FACTORS AFFECTING DRUG RESPONCES
GENETICS REVISION
EFFECTS OF POLYMORPHISMS IN DRUG RESPONCES
FUTURE OF PHARMACOGENOMICS
LIMITATIONS OF PHARMACOGENOMICS
PHARMACOGENOMICS IN INDIA

References:
Langman, L., & Dasgupta, A. (2012). Pharmacogenomics in Clinical Therapeutics. Retrieved from
http://books.google.com/books?
hl=en&lr=&id=mT7bQz5lsYsC&oi=fnd&pg=PR5&dq=Pharmacogenomics+in+Clinical+Therapeutics&ots=TWeGJL4TA
z&sig=GqxQChNkdaxf7rtkPy0CODKyq9A
Agrawal, S., & Khan, F. (2007). REVIEW ARTICLE HUMAN GENETIC VARIATION AND PERSONALIZED MEDICINE,
51(1), 728.
DeGorter, M. K., Xia, C. Q., Yang, J. J., & Kim, R. B. (2012). Drug transporters in drug efficacy and toxicity. Annual review of
pharmacology and toxicology, 52, 24973. doi:10.1146/annurev-pharmtox-010611-134529
Evans, W. E., & McLeod, H. L. (2003). Pharmacogenomics--drug disposition, drug targets, and side effects. The New England
journal of medicine, 348(6), 53849. doi:10.1056/NEJMra020526
Brunton, Chabnor, Knollman (2012) Goodman and Gillmans The Pharmacological Basis of Therapeutics, 12 th Ed, Chapter 7Pharmacogenomics, Page 142-188